BioNTech SE (ETR:22UA)
Germany · Delayed Price · Currency is EUR 89.00
-2.85 (-3.10%)
At close: Aug 26, 2025, 5:30 PM CET
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€425,044
Profits / Employee
€50,916
Market Cap
21.61B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
BioNTech SE News
- 1 day ago - Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Benzinga
- 8 days ago - Pfizer/BioNTech updated COVID vaccine authorized in Canada - Seeking Alpha
- 12 days ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Wallstreet:Online
- 12 days ago - CureVac's 2025 Mid-Year Financial Surge & Key Business Insights - Wallstreet:Online
- 15 days ago - Pfizer/BioNTech may not win FDA renewal for pediatric COVID shot: report - Seeking Alpha
- 19 days ago - GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled - Seeking Alpha
- 19 days ago - GSK to be paid up to £370 million after patent row settles in US - Evening Standard
- 19 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters